生命エネルギーを集約し
人類の健康を守る
証券コード: 603520
2022 | keep out over new conscientiousness relentlessly resourceful
2022-01-01
Spring is approaching, the new dollar is coming, and the year full of expectation and hope is coming. Starry pharmaceutical management team would like to extend our holiday wishes to our employees, their families, partners and friends from all walks of life who care and support the development of Starry.
When the path is long and obstructed, it will come. From "pharmaceutical" to "pharmaceutical", the strategic layout of the ground.
In 2021, Shanghai Starry iohexol and iodixanol injection won in fifth national cetralized bidding, sign company too stand iodine contrast agent further deepen the whole industry chain layout, further from the product end practice "polymerize life energy Care for human health "business philosophy, in the future will be more actively contribute to the broad masses of the people's health.
Travel far, Benedict line is not idle. "Rich" and "endowed" energy, scale and quality.
2021 is the first year of the "14th Five-year Plan", the country proposed to strongly support the development of featured apis and innovative apis, Starry factories around the active layout of capacity construction, 2021 completed or under construction, Zhejiang factory more than 600 tons; Jiangxi factory over 1000 tons; Poseidon plant exceeds 2000 tons. Shanghai factory, while making great efforts to guarantee collective procurement and supply, started the whole link linkage intelligent transformation project of 15 million bottles of iodine contrast agent. At the same time, the whole management team continued to promote lean production, the implementation of EAM equipment management system, the establishment of safety management red line, the launch of PI4 talent training project phase 4... Keep improving on the road of management upgrading.
Line and stop, the future can be. With research and development as the core, we will create development engines.
In 2021, Shanghai Starry won the qualification of high-tech enterprise, realizing the "Grand Slam" of high quality factories in four places, witnessing our continuous investment in RESEARCH and development in the past. In 2022, we will gather and integrate superior resources, vigorously expand the business segment of new products, and create another engine for the sustainable development of Starry.
2021 is a year of constant change and rapid growth. The past is a prologue to the future. I wish you all the best in the New Year.
Hu Jian
December 31, 2021
関連ニュース
お問い合わせ
電話番号: 0576-87718628/021-37916067
浙江司太立製薬股份有限公司
住所: 浙江省台州市仙居県現代工業集聚区司太立大道1号
上海司太立製薬有限公司
住所: 上海市金山工業区茂業路500号
浙江台州海神製薬有限公司
住所: 浙江省化学原薬基地臨海園区
江西司太立製薬有限公司
住所: 江西省宜春市樟樹市樟樹市工業園区
Imax Diagnostic Imaging Limited
住所: Phoenix House, Room 137 Monahan Road, CorkT12H1XY Republic of lreland
メール: info@imaxdiagnostic.com
電話番号: 00353 21 451 9990
メッセージをお願いします